Farhad Alvandifar

Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44+ cancer cells

Nazanin Shabani Ravari, Navid Goodarzi, Farhad Alvandifar et al. · DARU Journal of Pharmaceutical Sciences · 2016 · 44 citations · Full text

cis-Dichlorodiamminoplatinum (II) glyconanoparticles by drug-induced ionic gelation technique targeted to prostate cancer: Preparation, optimization and in vitro characterization

Soheyl Jafari Malek, Reyhaneh Khoshchehreh, Navid Goodarzi et al. · Colloids and Surfaces B Biointerfaces · 2014 · 22 citations

Nanomedicine, Medicinal Chemistry, Urology +9

Validating a stability indicating HPLC method for kinetic study of cetirizine degradation in acidic and oxidative conditions.

Effat Souri, Ali Reza Hatami, Nazanin Shabani Ravari et al. · PubMed · 2013 · 18 citations · Full text

Hplc Method, Acidic Degradation, Engineering +19

Optimization of paclitaxel-loaded poly (<scp>d</scp>,<scp>l</scp>-lactide-co-glycolide-N-<i>p</i>-maleimido benzoic hydrazide) nanoparticles size using artificial neural networks

Seyed Hossein Mostafavi, Mahdi Aghajani, Amir Amani et al. · Pharmaceutical Development and Technology · 2014 · 13 citations

Nanoparticles, Nps Size, Engineering +19

Dual drug delivery system of PLGA nanoparticles to reverse drug resistance by altering BAX/Bcl-2

Farhad Alvandifar, Baharnaz Ghaffari, Navid Goodarzi et al. · Journal of Drug Delivery Science and Technology · 2018 · 12 citations

Nanomedicine, Engineering, Polymer-drug Conjugate +8